Preclinical

Despite COVID-19, pharma R&D funding at all-time high: IQVIA

01-Jun-2021 By Jenni Spinner

According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.

Newly launched ‘skunkworks’ firm seeks to elevate drug development

27-May-2021 By Jenni Spinner

Created by an industry veteran with more than 20 years’ experience, Protodigm aims to offer innovation and expertise to pharmaceutical industry clients.

Sanofi and GSK take COVID-19 vaccine into Phase 3 study

27-May-2021 By Rachel Arthur

Sanofi and GSK have started the Phase 3 study for their COVID-19 vaccine candidate: eying up potential regulatory authorization in Q4, 2021.

Ampac announces $25m expansion of pharma manufacturing facility

19-May-2021 By Jenni Spinner

The company is enhancing its Virginia facility to add an east coast presence for its Analytical Labs division and enhance R&D for pharma ingredients.

Novasep expands in France, sees increasing customer demand for ADC manufacturing services

14-May-2021 By Jane Byrne

Novasep has announced a further expansion of its Highly Potent Active Pharmaceutical Ingredients (HPAPIs) manufacturing capabilities at its Le Mans, France site, saying the move strengthens its position as a leading CDMO for the production of innovative...

Explore vital drug delivery innovations at online event

03-May-2021 By Jenni Spinner

On May 5, a panel of experienced industry experts will discuss recent developments during Innovations in Drug Delivery, a free one-hour industry webinar.

Cancer detection tech uses AI, whole-genome sequencing

22-Apr-2021 By Jenni Spinner

An advanced cancer detection platform from C2i Genomics (reportedly capable of spotting miniscule traces of the disease) recently landed $100m in funding.

COVID-19 highlights need for digital lab connectivity: Waters

22-Apr-2021 By Jenni Spinner

A leader from the laboratory solutions provider talks about how the virus has created challenges for researchers, and how those obstacles might be cleared.

Immunomics firm reels in $14m to advance drug discovery

20-Apr-2021 By Jenni Spinner

ImmunoScape plans to use the investor funds to grow its Asia presence, expand into the US, and to further develop its Deep Immunomics platform technology.

FHIR can help tackle daunting digital challenges in research

19-Apr-2021 By Jenni Spinner

A leader from digital health solutions firm CitiusTech suggests use of fast healthcare interoperability resources is useful in the face of evolving tech.

Thermo Fisher Scientific snaps up PPD in $17.4b acquisition deal

15-Apr-2021 By Jenni Spinner

The science service and technologies firm plans to bring the CRO under its Laboratory Products and Services Segment umbrella after the deal is completed.

Cyclica teams with academics to investigate COVID-19 treatment

14-Apr-2021 By Jenni Spinner

The drug-discovery firm has partnered with several academic institutions to explore a Novartis lung-cancer treatment’s potential in treating COVID-19.

Research institute taps into RWE to assess angioedema therapies

13-Apr-2021 By Jenni Spinner

The Institute for Clinical and Economic Review will use Aetion observational real-world evidence to evaluate potential drugs from Takeda and CSL Behring.

Novartis, Artios cancer discovery deal worth up to $1.3bn

12-Apr-2021 By Jenni Spinner

The collaboration centers on development of precision cancer treatments, through discovery and validation of next-generation DNA damage response targets.

Positive study results said to support deployment of assay system in cancer drug clinical trials

12-Apr-2021 By Jane Byrne

New research findings suggest that an immunotherapy assay enables determination of PD-L1 status in a high percentage of cancer patients and could guide personalized treatment selection.

Charles River, Valence Discovery partner on AI-aided drug design

08-Apr-2021 By Jenni Spinner

The collaboration will enable Charles River clients to access Valence’s artificial intelligence platform in their pharmaceutical development projects.

Dedicated dad hopes to run down cure for a rare disease

07-Apr-2021 By Jenni Spinner

A father of two boys with Duchenne muscular dystrophy is running the Austin Marathon to raise funds toward pursuit of a cure for the rare, fatal disease.

IQVIA completes acquisition of Q2 Diagnostics

05-Apr-2021 By Jenni Spinner

The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.

Berg taps into supercomputer to battle COVID-19 variants

01-Apr-2021 By Jenni Spinner

The advanced biotech analysis company is harnessing the power of a formidable supercomputer to discover potential treatments for the virus and mutations.

AI algorithm automates analysis of cystic fibrosis scans

30-Mar-2021 By Jenni Spinner

Artificial intelligence software company Thirona has released PRAGMA-AI, technology that automates and accelerates CT scans in cystic fibrosis analysis.

Pharma firms should harness synthetic data: Phesi report

30-Mar-2021 By Jenni Spinner

The first in a series of reports released by Phesi and Accenture points toward the benefits of increased use of synthetic data in clinical research.

Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies

25-Mar-2021 By Jane Byrne

A US court’s recent decision to find in favor of Sanofi and invalidate Amgen's broad antibody patent claims has biotech manufacturers concerned about how to preserve their IP.

Online health communities connect patients, trial teams

23-Mar-2021 By Jenni Spinner

Health Union offers patients dealing with a range of conditions ways to connect with valuable information, research opportunities and each other online.

Cancer research benefits from harnessing real-world data

22-Mar-2021 By Jenni Spinner

A leader from oncologist-founded trial tech specialists COTA shares how advanced data analysis can benefit cancer researchers and patients alike.

Certara takes on TrialAssure data anonymization solution

18-Mar-2021 By Jenni Spinner

The biosimulation specialist will harness TrialAssure's Anonymize software to help anonymize patient clinical data for its future research studies.

Report reveals gap between rare-disease drug spending, need

11-Mar-2021 By Jenni Spinner

The IQVIA and NORD study shows rare-disease treatments account for only 11% of new drug spending, but 80% of orphan products treat rare diseases alone.

RARE DISEASE DAY

Patient-centric approach key to rare disease research: Centogene

25-Feb-2021 By Jenni Spinner

A leader from the genetics diagnostic solutions company explains how putting the patient first can make the difference in orphan drug development.

SCOPE 2021

SCOPE 2021 to take on tough clinical trial challenges

24-Feb-2021 By Jenni Spinner

The annual event, moved to the virtual realm thanks to COVID-19, offers content on remote monitoring, drug development technology and other key topics.

Developing vaccines and therapeutics for virus variants: FDA releases new guidance

23-Feb-2021 By Rachel Arthur

The US Food and Drug Administration (FDA) has issued guidance for companies developing vaccines, diagnostics and therapeutics against new variants of SARS-CoV-2.

Parexel, NeoGenomics partner on oncology genomics project

18-Feb-2021 By Jenni Spinner

The two companies will work to advance precision cancer medicine by harnessing genomics data in trial design, recruitment, site selection and other areas

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

18-Feb-2021 By Jane Byrne

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

Imaging biomarkers driving clinical innovations: HealthMyne

16-Feb-2021 By Jenni Spinner

In the drive to advance personalized medicine, researchers are increasingly turning to radiomics to assist in the discovery of new types of biomarkers.

Blockchain could accelerate drug development: Bloqcube

15-Feb-2021 By Jenni Spinner

With pharma firms seeking solutions to get products in the hands of patients faster, one company believes blockchain technology could provide answers.

AHA training aids researchers with heart-to-heart talks

14-Feb-2021 By Jenni Spinner

The American Heart Association’s Heart of Communicating Science modules are designed to help experts break complex talk into easy-to-understand language.

Immunity-centric biotech firm lands $60m in Series A funding

11-Feb-2021 By Jenni Spinner

Immunai has secured a total of $80m in funding to develop and promote its efforts to harness machine learning to fuel advancement of novel immunotherapies.

Sanofi, MIT Jameel Clinic join to advance health research with AI

09-Feb-2021 By Jenni Spinner

The collaboration between the Jameel Clinic and pharma firm will harness artificial intelligence and machine learning in developing health solutions.

CELLINK launches all-in-one imager, single-cell dispenser

09-Feb-2021 By Jenni Spinner

The UP.SIGHT single-sell dispensing system is designed to boost efficiency in cell-line development workflows and offer double assurance of clonality.

World Cancer Day

Super Bowl player donates to help fund cancer research

04-Feb-2021 By Jenni Spinner

William Gholston, with the Tampa Bay Buccaneers football team, is donating to the Moffitt Cancer Center to fund research into cancer treatment disparities.

COVID-19 tools from Cerba aim to save researchers time

28-Jan-2021 By Jenni Spinner

The company has released two products designed to help clinical researchers accelerate development of treatments and vaccines for the COVID-19 virus.

Paradigm4, 54gene collaborate on African clinical data

26-Jan-2021 By Jenni Spinner

With fewer than 3% of analyzed genomes currently coming from Africans, the companies are looking to increase access to and understanding of patient data.

Widening access to COVID-19 data

18-Jan-2021 By Rachel Arthur

California information technology and services company Syntegra and the National Institutes of Health (NIH) have signed a partnership to 'democratize access to the largest set of COVID-19 patient records': with the use of Syntegra's synthetic...

AI-driven drug discovery collaboration to tackle neurological diseases

12-Jan-2021 By Jenni Spinner

Sosei Heptares and PharmEnable will harness artificial intelligence-enabled technology and advanced chemistry to explore neurological disease solutions.

Repurposing existing drugs accelerates discovery: XenoTech

12-Jan-2021 By Jenni Spinner

Exploring alternative uses for drugs tapped for other indications, can save considerable time and money in discovery, according to an expert from the CRO.

Lexaria broadens COVID-19 drug exploration program

11-Jan-2021 By Jenni Spinner

The drug delivery platform company is exploring the viability of remdesivir and other potential treatments for the virus using its DehydraTECH technology.

Phesi, Sensyne Health partner on synthetic arm tech for trials

07-Jan-2021 By Jenni Spinner

The two organizations will collaborate on development of synthetic arms for clinical studies, drawing from millions of patient records and trial subject.

Pediatric trial challenges highlighted in patient survey

04-Jan-2021 By Jenni Spinner

Conducted via a partnership between Parexel and CISCRP, the study reveals insights about the needs and concerns of pediatric patients and their families.

Clinical informatics company raises $21.5m to fund tech

23-Dec-2020 By Jenni Spinner

Ovation.io will harness the funding to develop software and data products supporting drug discovery and development, creating diagnostics and more.

‘Explosion’ of health data fuels pharma advances: Linguamatics

22-Dec-2020 By Jenni Spinner

A leader from the IQVIA company explains how the boom in the volume and quality of data, and advanced analysis, can speed and streamline drug development.

Collaboration to chart AI-generated map of the immune system

21-Dec-2020 By Jenni Spinner

A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.

Sanofi joins Aqemia to develop COVID-19 treatments

21-Dec-2020 By Jenni Spinner

The pharma firm will lend support to Aqemia’s high-tech drug discovery tools in order to work on discovery and development of therapies for the virus.